Oculis Holding AG (OCS)
(Delayed Data from NSDQ)
$17.94 USD
+0.10 (0.56%)
Updated Aug 6, 2025 09:30 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OCS 17.94 +0.10(0.56%)
Will OCS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OCS
YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains?
Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates
OCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Oculis Holding AG (OCS) Reports Q1 Loss, Tops Revenue Estimates
BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Earnings Preview: Oculis Holding AG (OCS) Q1 Earnings Expected to Decline
Other News for OCS
Oculis upsized loan facility to access up to CHF 100 million
Oculis Upsized Loan Facility to Access up to CHF 100 million | OCS Stock News
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial ...
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial ...
Leerink Partners Sticks to Its Buy Rating for Oculis Holding (OCS)